Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Homatropine hydrobromide
Drug ID BADD_D01076
Description Homatropine is an anticholinergic drug that acts as an antagonist at muscarinic acetylcholine receptors. It is present in antitussives, under the trade name Hycodan, in combination with hydrocodone (dihydrocodeinone) bitartrate indicated for the symptomatic relief of cough as oral tablets or solutions. Homatropine is included in subtherapeutic amounts as homatropine methylbromide to discourage deliberate overdosage. Homatropine hydrobromide has been administered as ophthalmic solutions as a cycloplegic to temporarily paralyze accomodation, and to induce mydriasis (the dilation of the pupil); however such therapeutic use has not been approved by the FDA to be safe and effective.
Indications and Usage
Marketing Status Not Available
ATC Code S01FA05
DrugBank ID DB11181
KEGG ID D01004
MeSH ID C100236
PubChem ID 6419941
TTD Drug ID Not Available
NDC Product Code 69205-749; 59390-192; 62068-375; 69205-039; 42385-749
Synonyms homatropine | homatropine, (3(S)-endo)-isomer | homatropine, exo-(+-)-isomer | I - Homatrine | Isopto Homatropine | Minims-Homatropin | AK-Homatropine | Homatropin - POS | homatropine hydrobromide, (endo-(+-)-isomer) | homatropine hydrochloride, (endo-(+-)-isomer) | homatropine sulfate (1:1), (3(R)-endo)-isomer | homatropine sulfate (1:1), (3(S)-endo)-isomer | homatropine sulfate (2:1), endo-isomer | Minims-Homatropine Hydrobromide
Chemical Information
Molecular Formula C16H22BrNO3
CAS Registry Number 51-56-9
SMILES CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Anhidrosis23.02.03.001--Not Available
Bladder dilatation20.03.01.007--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysarthria19.19.03.001; 17.02.08.001--
Eczema23.03.04.006--
Eye irritation06.04.05.003--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Neuromuscular blockade17.05.04.003--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Pain08.01.08.004--
Photophobia17.17.02.006; 06.01.01.004--
Pulse abnormal13.14.04.004--Not Available
Pyrexia08.05.02.003--
Thirst14.03.02.007; 08.01.09.021--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Vascular occlusion24.04.02.015--Not Available
Mental disorder19.07.01.002--Not Available
The 1th Page    1    Total 1 Pages